A Study of More Frequent Dosing of VCN-01 Combined With Standard Chemotherapy in Patients With Newly Diagnosed Metastatic Pancreatic Cancer

Clinical trial NCT07701486 · RECRUITING

Trial details

NCT number: NCT07701486
Sponsor: Theriva Biologics SL
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pancreas Cancer, Metastatic Pancreas Cancer, Stage IV Ductal Adenocarcinoma of the Pancreas

Start date: 2026-08-03
Primary completion: 2027-08-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.